Key Highlights

Risk & Performance

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

5 recruiting

N/A

1(100.0%)

1Total

N/A(1)

Loading network data...

Showing 7 of 7 trials

Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform

Role: lead

Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)

Role: lead

Artificial Intelligence Scalable Solution for ST Myocardial Infarction

Role: lead

Multicenter Study for the Validation of Willem AI: Aortic StenoSis Early Diagnosis With AI-electrocardiogram Study

Role: lead

Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

Role: lead

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

Role: lead

ST-segment Elevation Not Associated With Acute Cardiac Necrosis (LESTONNAC)

Role: lead

All 7 trials loaded